Novo Nordisk's pricing strategies in the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who may have accused the company of rate gouging, declaring the stark contrast among U.S. prices and people in Europe and copyright.Other serps associate your advert-click on behavior having a profile on you, which may be utilized afterward